Chemo Therapy | malecare.org

Clinical Benefit of Docetaxel or Enzalutamide After Progression on First-Line Abiraterone and Prednisone in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) *

Abiraterone acetate (AA) or Zytiga has demonstrated a survival benefit in the pre-chemotherapy setting for men with advanced prostate cancer that has become castrate resistant (mCRPC). As a result it is in widespread clinical use in the United States prior to the use of chemotherapy with docetaxel. Since its FDA approval post chemotherapy there has [...]

By Malecare|2017-10-19T10:48:05-04:00August 20th, 2014|abiraterone acetate, Advanced Prostate Cancer, Chemo Therapy, Cross Resistance, Drugs & Treatments, enzalutamide, Uncategorized, Understanding APC, Xtandi|0 Comments

Complementary and Alternative Medicine with Chemotherapy

The following was written and posted by Paul Edwards to the Advanced Prostate Cancer Online Support Group: The March 2014 issue of the Asia-Pacific Journal of Clinical Oncology published an article “Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?” by authors from University of Queensland [...]

By Malecare|2017-10-19T10:48:06-04:00August 6th, 2014|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, supplements, Uncategorized|0 Comments

Can Chemotherapy (Docetaxel) Be Enhanced By Zoledronic Acid Pretreatment in Resistant Prostate Cancer Cells *

Docetaxel is the only globally approved first-line chemotherapy for the treatment of castrate resistant prostate cancer. Yhe universal truth is that all men taking docetaxel will become refractory to the treatment. Zoledronic acid (ZA) is the most commonly used member of nitrogen-containing bisphosphonate family. By itself it has anti-tumor activity, including in prostate cancer. In [...]

By Malecare|2014-08-05T14:08:36-04:00August 5th, 2014|Advanced Prostate Cancer, ASCO, bisphosphonates, Chemo Therapy, Chemo Therapy Failure, Combination Therapy, Drugs & Treatments, Research, Uncategorized, Understanding APC, Zometa|0 Comments

What are the Clinical implications of Chemotherapy for Men with Advanced Prostate Cancer Under the Age of 60 years?

Yesterday’s post was about the use of chemotherapy (with docetaxel) for the treatment of men with advanced prostate cancer who were 80 years old or older. Today’s post is about the use of chemotherapy in men 60 years or younger. The research for both of these posts was performed by the same team of scientists [...]

By Malecare|2017-10-19T10:48:07-04:00July 22nd, 2014|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, Research, survival, Uncategorized, Understanding APC|0 Comments

Should Men Over the Age of 80 Years Consider Chemotherapy? *

Chemotherapy (chemo with docetaxel) has a reputation for being a difficult therapy loaded with many side effects. I believe that this reputation is overblown given that all of our new non-chemotherapies (other than Provenge) come with their own list of significant side effects. However, its reputation is in the minds of many, so men who [...]

By Malecare|2017-10-19T10:48:07-04:00July 21st, 2014|Advanced Prostate Cancer, Chemo Therapy, Drugs & Treatments, Research, Uncategorized, Understanding APC|1 Comment